Cornelius Supply Chain Pledge

Published: 15-Feb-2012
Ingredients Regulatory

European raw materials distributor has invested heavily in developing stringent quality procedures

The recent events that have been documented in the news concerning breast implants is a current example of why Cornelius has created its ‘Cornelius Supply Chain Pledge’.

The European raw materials distribution company with more than 75 years of experience has invested heavily in developing stringent procedures to ensure the quality of the materials it supplies.

‘We insist on the highest standards of ourselves and our supply partners so that our customers can buy with confidence,’ explained David Brown, managing director of Cornelius.

‘We check all our suppliers and validate their quality and systems to ensure that the goods we supply to customers are fit for purpose. The consequences of getting something like this wrong are too devastating to individual consumers and companies involved, and we will never compromise on our high standards.’

Under the Cornelius Supply Chain Pledge, all suppliers represented by the Cornelius Group are selected according to stringent standards, have robust quality systems, are audited, and meet legal and ethical standards.

Although Cornelius has been accredited to ISO 9000 since 1992 and embraced SA8000 in 2002, the company says it has always rejected the 'box ticking' approach and striven to use Quality Management Systems to add value both to its customers and principals. The introduction of the Cornelius Supply Chain Pledge demonstrates the company’s commitment to being the quality leader in the European chemical distribution field.

More information is available at: www.cornelius.co.uk/supply_chain_pledge

See more

You may also like

Ingredients

Cornelius Group achieves The Sunday Times listing

Read more
Cornelius rapid growth has been showcased in the inaugural The Sunday Times HSBC International Track 200

Trending Articles

  1. A-Z Color advances automated quality control in pharmaceutical label production EyeC inspection systems help deliver zero-error labels and GMP-compliant reliability
  2. IMed Group appoints Parminder Kalle as Chief Commercial Officer Parminder Kalle to lead IMed’s new chapter of international growth
  3. QInscribe unveils AI-powered medical writing to revolutionise regulatory submissions New medical writing service provider QInscribe reduces the time to generate a draft clinical study report (CSR) by 90% with a generative AI solution
  4. You need to be a subscriber to read this article.
    Click here to find out more.
    From stockpiles to smart supply chains: how industry wants to fix Europe’s drug shortages An EU-level stockpile may work, but only if it’s flexible, closely monitored and built with logistics in mind. Industry players say drug security will depend less on volume and more on data, digital oversight and early collaboration throughout the supply chain
  5. NICE raises cost-effectiveness thresholds to boost UK pharma innovation The UK government has confirmed that NICE will increase its cost-effectiveness thresholds to £25,000-£35,000 per QALY from April 2026, with the aim to support pharmaceutical companies and unlock patient access to new medicines

Upcoming event

From powder to granules: a deep dive into wet granulation methods

14 January 2026 | Virtual See all

You may also like

Ingredients

Cornelius Group achieves The Sunday Times listing

Cornelius rapid growth has been showcased in the inaugural The Sunday Times HSBC International Track 200
Ingredients

Directly compressible medicated chewing gum bases from Cafosa

Developing medicated chewing gum products is now within the reach of pharmaceutical companies
Ingredients

Cornelius Group continues with its focus on pharmaceutical r&d

Cornelius Group is continuing with the expansion of its pharmaceutical ingredients offer to fully support innovation in oral dosage forms
Ingredients

Cornelius opens Polish subsidiary

Chemical distributor adds food and pharma to C&T portfolio
Regulatory

Grifols gets nod from European Medicines Agency for entire value chain of Grifols Egypt

The institution's certification endorses the entire plasma value chain under the highest European standards and opens the door for Egypt to, once domestic needs are met, export to other markets including Europe
Regulatory

Regulating innovation: a new focus on digital mental health technologies (DMHTs)

IMed Consultancy’s Benjamin Austin provides a clear understanding of how digital mental health technologies are innovating care and describes the evolving regulatory frameworks that ensure their safety and effectiveness
Regulatory

ten23 health QC lab to support commercial product testing for US customer following FDA approvals

This pivotal regulatory milestone enables FDA-compliant release and stability testing for injectable drug products throughout the clinical and commercial phases, in addition to manufacturing the commercial product
Subscribe now